ID4- A COST ANALYSIS OF LEVOFLOXACIN VERSUS CEFTRIAXONE IN ADULT INPATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Abstract
Authors
BE Rittenhouse AA Stinnett B Dulisse CJ Henke L Potter B Parasuraman LL Martens RR Williams C Kojak